Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data

被引：0
|
作者：
Sameh Gomaa
W. Kevin Kelly
Edith Mitchell
Eugene Storozynsky
Charnita Zeigler-Johnson
Hee-Soon Juon
Kuang-Yi Wen
机构：
[1] Thomas Jefferson University,Department of Medical Oncology
[2] Thomas Jefferson University,Department of Cardiology
[3] Fox Chase Cancer Center,Cancer Prevention and Control
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Disparities; Prostate cancer; Androgen deprivation therapy; Diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2351 / 2357
页数：6
相关论文
共 50 条
  • [31] New-Onset Diabetes Mellitus Is Not Associated with the Prognosis of Pancreatic Cancer
    Mizuno, Suguru
    Nakai, Yousuke
    Yamamoto, Keisuke
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Kogure, Hirofumi
    Sasaki, Takashi
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Isayama, Hiroyuki
    Tada, Minoru
    Kawabe, Takao
    Omata, Masao
    GASTROENTEROLOGY, 2009, 136 (05) : A390 - A390
  • [32] Androgen deprivation therapy, neoadjuvant androgen deprivation therapy, and adjuvant androgen deprivation therapy in patients with locally advanced prostate cancer: a multi-center real-world retrospective study
    Yi, Zhenglin
    Li, Huihuang
    Li, Mingyong
    Hu, Jiao
    Cai, Zhiyong
    Liu, Zhi
    Zhang, Chunyu
    Cheng, Chunliang
    He, Yunbo
    Chen, Jinbo
    Zu, Xiongbing
    Wang, Ruizhe
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [33] Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
    Keating, Nancy L.
    O'Malley, A. James
    Smith, Matthew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4448 - 4456
  • [34] New-onset diabetes mellitus among patients with glomerular diseases
    Lim, Cynthia C.
    Wong, Maggie W. Y.
    Koh, Hui L.
    Chin, Yok M.
    Mok, Irene Y. J.
    Choo, Jason C. J.
    INTERNAL MEDICINE JOURNAL, 2019, 49 (01) : 101 - 107
  • [35] Fracture risk in patients with prostate cancer on androgen deprivation therapy
    López, AM
    Pena, MA
    Hernández, R
    Val, F
    Martín, B
    Riancho, JA
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (06) : 707 - 711
  • [36] Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer
    Jonathan Assayag
    Hui Yin
    Serge Benayoun
    Michael N. Pollak
    Samy Suissa
    Laurent Azoulay
    Cancer Causes & Control, 2013, 24 : 839 - 845
  • [37] The influence of androgen deprivation therapy on metabolism in patients with prostate cancer
    Nishiyama, T
    Ishizaki, F
    Anraku, T
    Shimura, H
    Takahashi, K
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02): : 657 - 660
  • [38] Androgen deprivation therapy and the risk of tenosynovitis in prostate cancer patients
    Liu, Jui-Ming
    Liu, Dai-Wei
    Chuang, Heng-Chang
    Wu, Chun-Te
    Lin, Chien-Yu
    Hsu, Ren-Jun
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (07) : 1113 - 1119
  • [39] Antifracture agents for prostate cancer patients on androgen deprivation therapy
    Singh, Bhupendra P.
    Goel, Apul
    Gupta, Ankush
    INDIAN JOURNAL OF UROLOGY, 2010, 26 (01) : 149 - +
  • [40] Survey on preferences of androgen deprivation therapy in prostate cancer patients
    Cheung, B. C. S.
    Yuen, V. W. F.
    Teoh, J. Y. C.
    Chiu, P. K. F.
    Ng, C. F.
    BJU INTERNATIONAL, 2023, 131 : 14 - 15
12345